-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Professor Wang Junfeng from the Strong Magnetic Field Laboratory of the Hefei Institute of Physics and international scholars jointly developed a new type of circular replacement photo-oxygen voltage 2 (LOV2) to expand the functional library of genetically encoded optical switches
The LOV2 domain is a blue photosensitive light switch
In this study, the researchers designed cpLOV2 using circular permutation, a powerful protein engineering method that was previously used to evolve genetically encoded fluorescent probes and new variants of biocatalysts
Using high-resolution NMR and other technologies, the researchers proved that the structural integrity and function of cpLOV2 light-induced Jα dissociation are maintained well
cpLOV2 provides more options for the application and development of optogenetics
For effectors that need a free N-terminal to perform all their functions, cpLOV2 is a better choice
Chimeric antigen receptor (CAR) T cell therapy has become a promising immunotherapy method
In a mouse model implanted with CD19+ Raji cells, the researchers used up-conversion nanoparticles (UCNPs) to convert high tissue-penetrating near-infrared light into blue light, activate the injected optoCAR-T cells, and achieve high efficiency for lymphoma Treatment
These encouraging results indicate that optoCAR-T cells can reduce potential side effects without losing the therapeutic effect
# # #